Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03628599 · ClinicalTrials.gov registry record · NA
Two Daily Disposable Contact Lenses in Symptomatic Patients
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT03628599 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 39 participants.
The verdict
NCT03628599, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the performance of DAILIES TOTAL1® and ACUVUE OASYS® 1-DAY and with respect to visual acuity in a symptomatic study population of monthly or bi-weekly replacement lens wearers.
Interventions
- DEVICE Delefilcon A contact lenses
- DEVICE Senofilcon A contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2018-08-13 |
| Est. Completion | 2018-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03628599
The ClinicalTrials.gov registry entry for NCT03628599 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Delefilcon A contact lenses is the first listed.
NCT03628599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03628599 about?
NCT03628599 is a clinical study titled "Two Daily Disposable Contact Lenses in Symptomatic Patients". The purpose of this study is to evaluate the performance of DAILIES TOTAL1® and ACUVUE OASYS® 1-DAY and with respect to visual acuity in a symptomatic study population of monthly or bi-weekly replacement lens wearers.
What is the current status of trial NCT03628599?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2018-08-13. Estimated completion is 2018-09-25.
What interventions are being tested in trial NCT03628599?
The interventions under investigation include: Delefilcon A contact lenses (DEVICE), Senofilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT03628599?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.